Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Molecular Targets of Antidepressants
Małgorzata Jarończyk, Jarosław Walory
Molecules (2022) Vol. 27, Iss. 2, pp. 533-533
Open Access | Times Cited: 24

Showing 24 citing articles:

Exploring Zn(II)-Acetyl l-carnitine complex for simultaneous management of depression, chronic pain, and neuroprotection
Janetsi Y. Caro‐Ramírez, Leah V. Bazan, Oscar E. Piro, et al.
Journal of Inorganic Biochemistry (2025) Vol. 267, pp. 112857-112857
Closed Access
The light-dark forced swim test for simultaneous assessment of behavioral ‘despair’ and anxiety-like behavior in female mice
Sergey L. Khatsko, Alexander V. Zhdanov, Daria V Kravchenko, et al.
Behavioural Brain Research (2025) Vol. 484, pp. 115492-115492
Closed Access
Synthesis of anti-depressant molecules via metal-catalyzed reactions: a review
Aqsa Kanwal, Uzma Afzal, Muhammad Zubair, et al.
RSC Advances (2024) Vol. 14, Iss. 10, pp. 6948-6971
Open Access | Times Cited: 2
Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances
Caio Henrique Pinke Rodrigues, Lívia Salviano Mariotto, Jade Simões Castro, et al.
Forensic Toxicology (2023) Vol. 41, Iss. 2, pp. 187-212
Closed Access | Times Cited: 6
Review of Herbal Medicines for the Treatment of Depression
Siqi Peng, Yalan Zhou, Lu Meng, et al.
Natural Product Communications (2022) Vol. 17, Iss. 11
Open Access | Times Cited: 8
5-HT_FAsTR: a versatile, label-free, high-throughput, fluorescence-based microplate assay to quantify serotonin transport and release
Lina Bukowski, M. Ström, Jens Lindengren Andersen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Advances in Psychotropic Treatment for Pregnant Women: Efficacy, Adverse Outcomes, and Therapeutic Monitoring
Bárbara Costa, Nuno Vale
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4398-4398
Open Access | Times Cited: 1
Design and Synthesis of Potential Multi-Target Antidepressants: Exploration of 1-(4-(7-Azaindole)-3,6-dihydropyridin-1-yl)alkyl-3-(1H-indol-3-yl)pyrrolidine-2,5-dione Derivatives with Affinity for the Serotonin Transporter
Martyna Z. Wróbel, Andrzej Chodkowski, Agata Siwek, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11276-11276
Open Access | Times Cited: 1
Statins in depression: a repurposed medical treatment can provide novel insights in mental health
Riccardo De Giorgi, Philip J. Cowen, Catherine J. Harmer
International Review of Psychiatry (2022) Vol. 34, Iss. 7-8, pp. 699-714
Open Access | Times Cited: 7
Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder
Marco Paolini, L. Fortaner-Uyà, Cristina Lorenzi, et al.
Genes (2023) Vol. 14, Iss. 11, pp. 2037-2037
Open Access | Times Cited: 3
1-(Phenylselanyl)-2-(p-tolyl)indolizine: A selenoindolizine with potential antidepressant-like activity in mice mediated by the modulation of dopaminergic and noradrenergic systems
Marcia Juciele da Rocha, Marcelo Heinemann Presa, Gustavo D’Avila Nunes, et al.
Brain Research (2024) Vol. 1834, pp. 148904-148904
Closed Access
May the SSRIs play a role in the onset of peri- and post-menopausal cervical cancer?
Ciro Gargiulo Isacco, Raffaele Del Prete, Pietro Distratis, et al.
Deleted Journal (2024) Vol. 6, Iss. 7
Open Access
Treatment-Resistant Depression and Medications
Syed Iqbal, Kirti Saxena, Amir Lateef, et al.
Psychiatric Annals (2024) Vol. 54, Iss. 6
Closed Access
Perry Disease: Current Outlook and Advances in Drug Discovery Approach to Symptomatic Treatment
Z Gajda, Magdalena Hawrylak, Jadwiga Handzlik, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10652-10652
Open Access
Neuroplasticity and Mechanisms of Action of Acute and Chronic Treatment with Antidepressants in Preclinical Studies
Gilberto Uriel Rosas-Sánchez, León Jesús Germán-Ponciano, Gabriel Guillén-Ruiz, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2744-2744
Open Access
Beyond NMDA Receptors: A Narrative Review of Ketamine’s Rapid and Multifaceted Mechanisms in Depression Treatment
Z Antoś, Xawery Żukow, Laura Bursztynowicz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13658-13658
Open Access
Investigating the Antidepressant Impact of Ethanolic Extract of Melilotus officinalis Fruit in Mouse Models
Gustavo Roberto Villas Boas, Ana Paula Stefanello da Silveira, Brunna Charlla Feitosa Farinelli, et al.
International Journal of Pharmaceutical and Phytopharmacological Research (2024) Vol. 14, Iss. 6, pp. 21-27
Closed Access
Introduction
Andrea Fagiolini, Alessandro Cuomo, Roger S. McIntyre
(2024), pp. 1-6
Closed Access
Brain derived neurotrophic factor has a role in the antidepressant effect of atorvastatin and fenofibrate in Wistar rats
Eman Ali, Azza Abouelella
Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences (2022) Vol. 6, Iss. 3, pp. 179-194
Open Access | Times Cited: 2
Drug discovery: Standing on the shoulders of giants
Susan M. Miller, Walter H. Moos, Barbara H. Munk, et al.
Elsevier eBooks (2023), pp. 207-338
Closed Access
5-HT_FAsTR: A versatile, label-free, microplate assay to quantify serotonin transport and release using the genetically encoded fluorescent biosensor iSeroSnFR
Lina Bukowski, M. Ström, Jens Lindengren Andersen, et al.
Research Square (Research Square) (2023)
Open Access
Psychotherapy, pharmacotherapy, and their combination in the treatment of major depressive disorder: How well are we making use of available therapies?
Ingrid Nădășan, Gabriel Hancu
Acta Marisiensis. Seria Medica (2023) Vol. 69, Iss. 4, pp. 244-251
Open Access
1,5-Dichloroethanoanthracene Derivatives As Antidepressant Maprotiline Analogs: Synthesis, DFT Computational Calculations, and Molecular Docking
Mujeeb A. Sultan, Renjith Raveendran Pillai, Eman Alzahrani, et al.
Journal of Chemistry (2022) Vol. 2022, pp. 1-11
Open Access
ADVANCES IN TREATMENT OF MOOD DISORDERS
Asim A. Shah
Journal of Pakistan Psychiatric Society (2022) Vol. 19, Iss. 04, pp. 4-5
Open Access
Page 1

Scroll to top